Porto-sinusoidal vascular disease: a view through a new paradigm. Lecture

The lecture presents the current data on porto‑sinusoidal vascular disease (PSVD), which is a rare vascular disease of the liver that, in the vast majority of cases, is accompanied by the development of portal hypertension in the absence of liver cirrhosis and is mostly underdiagnosed due to a lack of knowledge about this pathology. Brief historical information on the sequence of study of PSVD and changes in the understanding of the root causes of this pathology are presented. The lack of unanimous opinion of the leading hepatological societies — Baveno VII, European Association for the Study of the Liver (EASL), Vascular Liver Diseases Interest Group (VALDIG), American Association for the Study of Liver Diseases (AASLD), Asian Pacific Association for the Study of the Liver (APASL) — on the terminology and management of patients with PSVD is emphasized. Modern diagnostic criteria for VALDIG are described, and the characteristic features detected during instrumental imaging studies (absence of nodular changes on the liver surface, hypertrophy of segments IV and I against the background of unchanged or slightly increased liver stiffness along with signs of portal hypertension) are noted. It is emphasized that a mandatory requirement for the diagnosis of PSVD is a liver biopsy and the detection of some specific histological signs of the disease (obliterating portal venopathy, nodular regenerative hyperplasia, incomplete septal fibrosis). It is noted that the course of PSVD is complicated by bleeding from varicose veins, ascites, and hepatic encephalopathy. Current views on the treatment of patients with PSVD are similar to the management of patients with cirrhosis: therapy is aimed at combating complications of portal hypertension and preventing their occurrence. Opposing views on the long‑term prognosis of PSVD are presented: in general, it is considered relatively favorable, but it can worsen with the development of concomitant portal hypertension.

Authors

Institutions

Publication Details

Journal
Modern Gastroenterology
Published
2025-09-26
DOI
https://doi.org/10.30978/mg-2025-3-74
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Porto-sinusoidal vascular disease: a view through a new paradigm. Lecture

N. B. Gubergrits, Nadiia Bieliaieva, O. A. Gomozova, T. L. Mozhynа
Modern Gastroenterology
Cerebrovascular and Carotid Artery Diseases
article

Porto-sinusoidal vascular disease: a view through a new paradigm. Lecture

N. B. Gubergrits, Nadiia Bieliaieva, O. A. Gomozova, T. L. Mozhynа
article en

Abstract

The lecture presents the current data on porto‑sinusoidal vascular disease (PSVD), which is a rare vascular disease of the liver that, in the vast majority of cases, is accompanied by the development of portal hypertension in the absence of liver cirrhosis and is mostly underdiagnosed due to a lack of knowledge about this pathology. Brief historical information on the sequence of study of PSVD and changes in the understanding of the root causes of this pathology are presented. The lack of unanimous opinion of the leading hepatological societies — Baveno VII, European Association for the Study of the Liver (EASL), Vascular Liver Diseases Interest Group (VALDIG), American Association for the Study of Liver Diseases (AASLD), Asian Pacific Association for the Study of the Liver (APASL) — on the terminology and management of patients with PSVD is emphasized. Modern diagnostic criteria for VALDIG are described, and the characteristic features detected during instrumental imaging studies (absence of nodular changes on the liver surface, hypertrophy of segments IV and I against the background of unchanged or slightly increased liver stiffness along with signs of portal hypertension) are noted. It is emphasized that a mandatory requirement for the diagnosis of PSVD is a liver biopsy and the detection of some specific histological signs of the disease (obliterating portal venopathy, nodular regenerative hyperplasia, incomplete septal fibrosis). It is noted that the course of PSVD is complicated by bleeding from varicose veins, ascites, and hepatic encephalopathy. Current views on the treatment of patients with PSVD are similar to the management of patients with cirrhosis: therapy is aimed at combating complications of portal hypertension and preventing their occurrence. Opposing views on the long‑term prognosis of PSVD are presented: in general, it is considered relatively favorable, but it can worsen with the development of concomitant portal hypertension.

Modern Gastroenterology(3)
Hellenic Petroleum (Greece) (GR), Alpha Genesis (United States) (US), Physical Sciences (United States) (US), Spectrum Scientific (United States) (US), International Society of Automation (US), Institut National de la Recherche Agronomique de Tunisie (TN), Human Growth Foundation (US)
Openalex Percentile: Top 62%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.